Le Lézard
Classified in: Health
Subject: PLW

Biocoat, Inc.'s HYDAK® UV Hydrophilic Coating Awarded USPTO Patent


HORSHAM, Pa., July 26, 2022 /PRNewswire/ -- Biocoat, Inc., a specialty manufacturer of hydrophilic biomaterial coatings, services and dip-coating equipment for medical devices, today announced that its HYDAK® UV coating has been approved for a patent by the United States Patent and Trademark Office (USPTO).

"Biocoat's HYDAK UV coating is built on a bi-laminar platform that offers industry-leading results in lubricity, durability and particulates, which are the main criteria for measuring hydrophilic coating performance," said Dr. Bob Hergenrother, Biocoat's Vice President of Research, Development, and Innovation. "The acceptance of our USPTO filing confirms that our unique and proprietary technology is unmatched in the marketplace."

Biocoat is the only hydrophilic coating provider to offer industry-leading performance using both UV and Thermal Heat curing systems. UV cure coatings are used on many medical devices that require a hydrophilic coating, particularly in the cardiovascular market. Thermal curing is often used on interventional medical devices that require extremely high-performance results. In addition, Thermal curing may be used for coating the inner diameter of the substrate materials or for use on the delivery cartridges used to place intraocular lenses (IOLs).

"Our HYDAK UV coating was introduced to the market in early 2020 and since then, we have had significant interest from both current and new customers" said Jim Moran, President, and CEO, Biocoat. "The entire Biocoat team has worked tirelessly to support this new product launch, and we are proud to be recognized by this patent for our innovation. Our team is laser focused on ensuring that we offer customers the best hydrophilic coatings and product development support available in the industry today".

Scott Cramer, Board Chair for Biocoat, added, "The Biocoat team continues to innovate, which has pushed the organization to be recognized as the leading full-service hydrophilic coating company in the medical device industry."

About Biocoat, Inc.

Biocoat, Inc. is a full-service coatings provider specializing in supplying lubricious hydrophilic coatings custom engineered to meet specific clinical parameters for medical devices to original equipment manufacturers, start-up companies, and contract manufacturers. Biocoat also provides coating services and dip-coating equipment to medical device companies that require assistance with manufacturing.

To learn more about Biocoat visit www.biocoat.com, call +1 215-734-0888 or connect on LinkedIn and Twitter.

SOURCE Biocoat, Inc.


These press releases may also interest you

at 15:52
Getlabs, the nationwide leader for at-home diagnostics, is excited to announce a strategic partnership with Instalab, a pioneering proactive healthcare company. Through Getlabs' widespread presence throughout the United States, Instalab can provide...

at 15:45
Core Sound Imaging, creator of the Studycast system, today announces that Core Sound Imaging was named a 2024 SIIA CODiE Award Finalist in the Most Innovative Tech Company category. CODiE Finalists represent the best products, services and people in...

at 15:43
Today marks the release of the 2024 National Strategy for Suicide Prevention, an important milestone and rallying point for organizations nationwide working to address this important public health issue. The American Foundation for Suicide Prevention...

at 15:28
A case management hearing in the above-named matter is scheduled to be heard on April 23, 2024 at 4:30 p.m. by videoconference.  Members of the public may observe the hearing by videoconference, by selecting the "Register to attend" link on the...

at 15:14
Cymbiotika, a trailblazer in health and wellness, is thrilled to announce the launch of its new pet line, meticulously crafted to enhance the health and vitality of beloved pets. The new line includes four revolutionary products: Probiotic+, Calm,...

at 15:00
TELUS Health revealed today the results of its 2024 Drug Data Trends and National Benchmarks Report at its 20th annual TELUS Health Conference, running today and April 30. Diabetes medications remain the leading drug category for eligible private...



News published on and distributed by: